Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Galera Therapeutics, Inc. (GRTX)

Compare
0.0300
0.0000
(0.00%)
At close: April 1 at 9:45:04 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
17,706
46,951
51,226
73,368
70,553
Operating Income
-17,706
-46,951
-51,226
-73,368
-70,553
Net Non Operating Interest Income Expense
61
-9,819
-11,065
-7,162
-3,706
Other Income Expense
-2,171
-2,312
-1
-4
25
Pretax Income
-19,816
-59,082
-62,292
-80,534
-74,234
Tax Provision
-203
--
-70
--
-16
Net Income Common Stockholders
-19,613
-59,082
-62,222
-80,534
-74,218
Diluted NI Available to Com Stockholders
-19,613
-59,082
-62,222
-80,534
-74,218
Basic EPS
-0.29
-1.33
-2.30
-3.12
-2.98
Diluted EPS
-0.29
-1.33
-2.30
-3.12
-2.98
Basic Average Shares
54,417.4030
44,549.2850
27,086.6640
25,789.4580
24,869.7700
Diluted Average Shares
54,417.4030
44,549.2850
27,086.6640
25,789.4580
24,869.7700
Total Operating Income as Reported
-19,870
-49,260
-51,226
-73,368
-70,553
Total Expenses
17,706
46,951
51,226
73,368
70,553
Net Income from Continuing & Discontinued Operation
-19,613
-59,082
-62,222
-80,534
-74,218
Normalized Income
-17,464.2403
-56,770
-62,221.0010
-80,530
-74,242.9946
Interest Income
766
1,595
506
32
1,174
Interest Expense
705
11,414
11,571
7,194
4,880
Net Interest Income
61
-9,819
-11,065
-7,162
-3,706
EBIT
-19,111
-47,668
-50,721
-73,340
-69,354
EBITDA
-18,876
-47,409
-50,607
-72,562
-68,986
Reconciled Depreciation
235
259
114
778
368
Net Income from Continuing Operation Net Minority Interest
-19,613
-59,082
-62,222
-80,534
-74,218
Total Unusual Items Excluding Goodwill
-2,171
-2,312
-1
-4
25
Total Unusual Items
-2,171
-2,312
-1
-4
25
Normalized EBITDA
-16,705
-45,097
-50,606
-72,558
-69,011
Tax Rate for Calcs
0
--
0
--
0
Tax Effect of Unusual Items
-22.2403
--
-0.0010
--
0.0054
12/31/2020 - 11/7/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYBX Synlogic, Inc.
1.2200
-1.61%
 
SEER Seer, Inc.
1.6600
-1.78%
 
IKNA Ikena Oncology, Inc.
1.2500
-2.34%
 
SPRB Spruce Biosciences, Inc.
0.2683
-7.51%
 
HLVX HilleVax, Inc.
1.3850
-4.48%
 
BOLT Bolt Biotherapeutics, Inc.
0.3830
-4.25%
 
THRD Third Harmonic Bio, Inc.
3.3600
-3.17%
 
OKUR OnKure Therapeutics, Inc.
4.2600
-0.93%
 
TBPH Theravance Biopharma, Inc.
9.02
+1.01%
 
KZR Kezar Life Sciences, Inc.
4.5100
-7.58%